BCL2 and treatment resistant depression: The four-week ECT protocol (bitemporal, three sessions per week, with MADRS evaluation and blood sampling after each week) in TRD patients resulted in a concomitant significant decrease in MADRS, Bax, and p53 and an increase in Bcl-2 expression.